Reports from the clinical trial registry and the literature, guides to clinical research, and real questions answered with citations.https://clinlit.com/https://clinlit.com/blog/how-to-benchmark-a-clinical-trial-design/https://clinlit.com/blog/how-to-benchmark-a-clinical-trial-design/A step-by-step method for checking a trial design's assumptions against earlier trials, their protocols and results, with questions to reuse and the traps to avoid.Tue, 10 Nov 2026 00:00:00 GMThow-totrial designsample sizeprotocolsstatistical analysis plansClinicalTrials.govPubMedhttps://clinlit.com/blog/how-to-design-a-phase-2b-mash-trial/https://clinlit.com/blog/how-to-design-a-phase-2b-mash-trial/Placebo response from 2% to 33%, screen failure up to 87%: what 219 phase 2 MASH trials and six protocols show about endpoints, sample size and biopsies.Tue, 10 Nov 2026 00:00:00 GMTMASHNASHtrial designsample sizeplacebo responsescreen failureprotocolsClinicalTrials.govhttps://clinlit.com/blog/how-accurate-is-clinlit-ai-accuracy-audit/https://clinlit.com/blog/how-accurate-is-clinlit-ai-accuracy-audit/We tested ClinLit AI on 50 new questions and checked each answer against ClinicalTrials.gov, PubMed and FDA sources. The results, with every error listed.Mon, 09 Nov 2026 00:00:00 GMTaccuracyevaluationAI agentsClinicalTrials.govPubMedFDAFAERShttps://clinlit.com/blog/eli-lilly-rd-profile-november-2026/https://clinlit.com/blog/eli-lilly-rd-profile-november-2026/Eli Lilly's clinical pipeline as of 7 November 2026: 240 active trials, its late-stage drugs, readouts due, FDA approvals, and how it compares with four peers.Sun, 08 Nov 2026 00:00:00 GMTcompany profileEli Lillypipelinecompetitive intelligenceClinicalTrials.govDrugs@FDAhttps://clinlit.com/blog/how-to-build-a-pharma-company-rd-profile/https://clinlit.com/blog/how-to-build-a-pharma-company-rd-profile/A step-by-step method for profiling a drug company's pipeline, trials, FDA record and peers from public data, with questions to reuse and the traps to check.Sun, 08 Nov 2026 00:00:00 GMThow-tocompany profilepipeline analysiscompetitive intelligenceClinicalTrials.govDrugs@FDAhttps://clinlit.com/blog/cleaning-openfda-faers-and-drug-label-data/https://clinlit.com/blog/cleaning-openfda-faers-and-drug-label-data/What it took to turn openFDA's FAERS reports, drug labels and approvals into linked, searchable data: the problems we hit, the fixes, and how we checked them.Sun, 25 Oct 2026 00:00:00 GMTopenFDAFAERSdrug labelsSPLUNIIDrugs@FDAdata qualitypharmacovigilancehttps://clinlit.com/blog/glp-1-adverse-events-faers/https://clinlit.com/blog/glp-1-adverse-events-faers/Ten years of serious FDA adverse event reports for semaglutide, tirzepatide and four other GLP-1 drugs: what stands out, from pancreatitis to NAION, and what it can't tell you.Sat, 24 Oct 2026 00:00:00 GMTFAERSpharmacovigilanceGLP-1semaglutidetirzepatidepancreatitisgastroparesisNAIONdrug labelshttps://clinlit.com/blog/which-clinical-trials-share-protocols-and-saps/https://clinlit.com/blog/which-clinical-trials-share-protocols-and-saps/Only 27% of recently completed trials have posted a protocol, SAP or consent form on ClinicalTrials.gov, and 46% have left no public trace. Who shares, who doesn't, and why.Wed, 21 Oct 2026 00:00:00 GMTClinicalTrials.govtrial protocolsstatistical analysis plansinformed consenttransparencyFDAAAPubMedhttps://clinlit.com/blog/glp-1-clinical-trials-beyond-diabetes-obesity/https://clinlit.com/blog/glp-1-clinical-trials-beyond-diabetes-obesity/340 trials test GLP-1 drugs in diseases other than diabetes and obesity, from heart failure and MASH to alcohol use and cancer. The data, the trials and their design.Tue, 20 Oct 2026 00:00:00 GMTGLP-1semaglutidetirzepatidetrial designclinical trial landscapehttps://clinlit.com/blog/how-we-researched-glp-1-trials-with-clinlit-ai/https://clinlit.com/blog/how-we-researched-glp-1-trials-with-clinlit-ai/A step-by-step walkthrough of using ClinLit AI to analyse ClinicalTrials.gov, trial protocols and PubMed: the questions we asked, the SQL it ran and how we checked it.Tue, 20 Oct 2026 00:00:00 GMThow-toClinicalTrials.govAACTPubMedtrial protocolsGLP-1